These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21257902)

  • 1. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience.
    Gonsalves CF; Eschelman DJ; Sullivan KL; Anne PR; Doyle L; Sato T
    AJR Am J Roentgenol; 2011 Feb; 196(2):468-73. PubMed ID: 21257902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
    Klingenstein A; Haug AR; Zech CJ; Schaller UC
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea.
    Gonsalves CF; Eschelman DJ; Thornburg B; Frangos A; Sato T
    AJR Am J Roentgenol; 2015 Aug; 205(2):429-33. PubMed ID: 25905562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
    Memon K; Kuzel TM; Vouche M; Atassi R; Lewandowski RJ; Salem R
    Melanoma Res; 2014 Jun; 24(3):244-51. PubMed ID: 24638152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
    Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
    Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
    J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Gonsalves CF; Eschelman DJ; Adamo RD; Anne PR; Orloff MM; Terai M; Hage AN; Yi M; Chervoneva I; Sato T
    Radiology; 2019 Oct; 293(1):223-231. PubMed ID: 31453767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.
    Heusner TA; Antoch G; Wittkowski-Sterczewski A; Ladd SC; Forsting M; Verhagen R; Scheulen M
    Rofo; 2011 Dec; 183(12):1151-60. PubMed ID: 22033849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization of liver metastases in patients with uveal melanoma.
    Huppert PE; Fierlbeck G; Pereira P; Schanz S; Duda SH; Wietholtz H; Rozeik C; Claussen CD
    Eur J Radiol; 2010 Jun; 74(3):e38-44. PubMed ID: 19467811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
    Schonewolf CA; Patel B; Gensure RH; Narra V; Haffty BG; Nosher JL; Jabbour SK
    Am J Clin Oncol; 2014 Jun; 37(3):234-40. PubMed ID: 23275270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
    Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
    J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J; Irani Z; Lawrence D; Flaherty K; Arellano RS
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.
    Gupta S; Bedikian AY; Ahrar J; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P
    Am J Clin Oncol; 2010 Oct; 33(5):474-80. PubMed ID: 19935383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events.
    Ricke J; Hildebrandt B; Miersch A; Nicolaou A; Warschewske G; Teichgräber U; Lopez Hänninen E; Riess H; Felix R
    J Vasc Interv Radiol; 2004 Aug; 15(8):825-33. PubMed ID: 15297586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.